Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06489587 · ClinicalTrials.gov registry record · NA

Creatine Supplementation At Simulated Altitude

A NA study of Exercise Performance, sponsored by California Polytechnic State University-San Luis Obispo.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06489587 is a NA study of Exercise Performance that is actively recruiting participants, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 60 participants, above the 24-participant average among 7 other Exercise Performance trials with a reported enrollment target (150% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06489587, a NA study of Exercise Performance, is actively recruiting participants, sponsored by California Polytechnic State University-San Luis Obispo.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Creatine supplementation has been shown to increase exercise performance at sea level. The goal of this study is to determine the effects of creatine supplementation on exercise performance at simulated altitude.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Creatine

Study Locations (1)

California

  • California Polytechnic State University - San Luis Obispo

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-06-25
Est. Completion 2026-06
Phase NA

What the Registry Record Tells You About NCT06489587

The ClinicalTrials.gov registry entry for NCT06489587 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 24-participant average among 7 other Exercise Performance trials with a reported enrollment target (150% higher). The listed sponsor is California Polytechnic State University-San Luis Obispo, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Exercise Performance appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06489587 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06489587 about?

NCT06489587 is a clinical study titled "Creatine Supplementation At Simulated Altitude". Creatine supplementation has been shown to increase exercise performance at sea level. The goal of this study is to determine the effects of creatine supplementation on exercise performance at simulated altitude.

What is the current status of trial NCT06489587?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-06-25. Estimated completion is 2026-06.

What conditions does trial NCT06489587 study?

This clinical trial studies the following conditions: Exercise Performance.

What interventions are being tested in trial NCT06489587?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Creatine (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06489587?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06489587 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise Performance

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.